• $1.7B
    Market Cap
  • 328.27%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
2.6M
N/A
N/A
N/A
42.8M
+65.28%
25.9M
-17.56%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
2.6M
N/A
0
-100.00%
42.8M
+65.28%
25.9M
-17.56%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-22.8M
+180.22%
-8.2M
-80.50%
-41.8M
-21.10%
-53.0M
-20.51%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
1.9M
-31.26%
2.8M
+12.65%
Total Operating Expenses
38.6M
+173.87%
14.1M
-80.58%
72.6M
+4.60%
69.4M
-16.66%
Operating Profit
-38.6M
+173.87%
-14.1M
-52.63%
-29.8M
-31.55%
-43.5M
-16.12%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
0
+100.00%
-430,000
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
+100.00%
-430,000
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
727,000
+42.27%
511,000
+304.40%
-250,000
-119.19%
1.3M
-45.80%
Income before Taxes
-41.7M
+139.27%
-17.4M
-41.41%
-29.8M
-31.55%
-43.5M
-4.95%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
13.9M
N/A
N/A
N/A
Net Income
-41.7M
+139.27%
-17.4M
-28.97%
-24.5M
-26.25%
-33.3M
-27.24%
Net Income from Continuing Operations Applicable to Common
-41.7M
+139.27%
-17.4M
-28.97%
-24.5M
-26.25%
-33.3M
-27.24%
Basic EPS and Net Income
-3.71
-52.62%
-7.83
+2,800.00%
-0.27
-40.00%
-0.45
-36.62%
Diluted EPS and Net Income
-3.71
-52.62%
-7.83
+2,800.00%
-0.27
-40.00%
-0.45
-36.62%
Basic Weighted Average Shares
11.3M
+405.46%
2.2M
-97.53%
90.1M
+21.43%
74.2M
+14.91%
Diluted Weighted Average Shares
11.3M
+405.46%
2.2M
-97.53%
90.1M
+21.43%
74.2M
+14.91%
Balance Sheet
Cash and Cash Equivalents
58.0M
-30.65%
83.6M
+380.58%
17.4M
-54.97%
38.6M
-67.19%
Short-Term Investments
N/A
N/A
N/A
N/A
9.0M
-56.32%
20.5M
N/A
Cash and Cash Equivalents and Short-Term Investments
58.0M
-30.65%
83.6M
+217.08%
26.4M
-55.44%
59.2M
-49.76%
Total Current Assets
59.0M
-33.15%
88.2M
+128.11%
38.7M
-47.32%
73.4M
-42.47%
Accumulated Depreciation
N/A
N/A
N/A
N/A
9.6M
0.00%
9.6M
+25.01%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
0
-100.00%
17.0M
-11.14%
Total Long-Term Assets
N/A
N/A
N/A
N/A
0
-100.00%
1.4M
-52.86%
Total Assets
59.6M
-32.50%
88.2M
+128.11%
38.7M
-59.49%
95.5M
-37.82%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
11.3M
-5.77%
12.0M
+0.97%
11.9M
-67.41%
36.6M
-27.65%
Total Long-Term Debt
5.0M
0.00%
5.0M
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
2.5M
+50.09%
1.6M
N/A
0
-100.00%
31.0M
N/A
Total Liabilities
31.6M
+23.21%
25.6M
+114.96%
11.9M
-82.35%
67.6M
-34.28%
Retained Earnings
-135.4M
+44.50%
-93.7M
-70.24%
-315.0M
+8.45%
-290.4M
+12.94%
Total Stockholders Equity
28.0M
-55.30%
62.6M
+133.97%
26.8M
-4.19%
27.9M
-44.97%
Total Shares Outstanding
12.4M
+12.43%
11.0M
-88.87%
98.9M
+32.76%
74.5M
+3.18%
Cash Flow
Cash from Operating Activities
-25.0M
+130.68%
-10.8M
-79.86%
-53.8M
-10.20%
-59.9M
+682.40%
Capital Expenditures
N/A
N/A
N/A
N/A
171,000
-83.57%
1.0M
+9.69%
Cash from Investing Activities
N/A
N/A
N/A
N/A
12.0M
+156.52%
-21.2M
+2,137.72%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-660,000
-100.76%
87.1M
+339.95%
19.8M
+174.40%
7.2M
-87.80%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,490.42%
N/A
N/A
N/A
-69.51%
-58.59%
-167.84%
+1.74%
Return on Assets
-56.45%
+105.47%
-27.47%
-24.90%
-36.58%
+36.90%
-26.72%
-24.46%
Return on Equity
-92.10%
+136.04%
-39.02%
-56.53%
-89.76%
+6.12%
-84.58%
-24.38%
Revenue Growth
N/A
N/A
N/A
N/A
65.28%
+471.80%
-17.56%
-345.74%
Current Ratio
5.20
-29.06%
7.33
+125.92%
3.24
+61.65%
2.01
-20.49%
Cash Ratio
5.11
-26.40%
6.94
+375.93%
1.46
+38.17%
1.06
-54.66%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow